Enanta Pharmaceuticals
ENTA
#8060
Rank
HK$3.01 B
Marketcap
HK$103.40
Share price
4.27%
Change (1 day)
11.02%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -HK$0.4 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are HK$65.25 Million. In 2025 the company made an earning of -HK$0.51 Billion, an increase over its 2024 earnings that were of -HK$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.4 Billion-21.83%
2025 -HK$0.51 Billion-34.07%
2024 -HK$0.77 Billion-23.87%
2023 -HK$1 Billion4.39%
2022 -HK$0.96 Billion-4.4%
2021 -HK$1.01 Billion91.12%
2020 -HK$0.53 Billion-407.13%
2019 HK$0.17 B-78.63%
2018 HK$0.79 B117.97%
2017 HK$0.36 B-574.65%
2016 -HK$77.2 Million-110.83%
2015 HK$0.71 B-4.5%
2014 HK$0.74 B-638.53%
2013 -HK$0.14 Billion-137.98%
2012 HK$0.36 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$205.60 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$121.77 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
HK$68.24 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$39.57 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$60.33 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.43 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA